Skip to Main Content

Paper Details

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies.
BMJ Open
8
2022
T2DM, dipeptidyl peptidase-4, glucagon-like peptide-1 receptor, glucose, hyperglycaemic, patients, sodium, sodium-glucose co-transporter, sulfonylureas, type 2 diabetes mellitus
Author NameAffiliation
Rohan KheraYale School of Medicine
Rohan KheraCenter for Outcomes Research and Evaluation, Yale University School of Medicine
Rohan KheraYale School of Medicine
Rohan KheraCenter for Outcomes Research and Evaluation, Yale University School of Medicine
Martijn J Schuemie
Martijn J SchuemieUniversity of California los angeles
Martijn J Schuemie
Martijn J SchuemieUniversity of California los angeles
Yuan LuYale School of Medicine
Yuan LuCenter for Outcomes Research and Evaluation, Yale University School of Medicine
Ruijun Chen
George HripcsakColumbia University Medical Center
George HripcsakNew York-Presbyterian Hospital
George HripcsakColumbia University Medical Center
George HripcsakNew York-Presbyterian Hospital
Patrick B Ryan
Patrick B RyanColumbia University Medical Center
Patrick B Ryan
Patrick B RyanColumbia University Medical Center
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale University School of Medicine
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale University School of Medicine
Marc A SuchardUniversity of California los angeles
Marc A SuchardUniversity of California los angeles
Marc A SuchardUniversity of California los angeles
Marc A SuchardUS Department of Veterans Affairs
Marc A SuchardUniversity of California los angeles
Marc A SuchardUniversity of California los angeles
Marc A SuchardUniversity of California los angeles
Marc A SuchardUS Department of Veterans Affairs
  • 1 - 31

Datasets